Protective effects of recombinant growth hormone on intestinal mucosa in rats receiving abdominal radiotherapy

Clinical Nutrition

Volumn 21, Issue 6, 2002, Pages 487-490

  Raguso, C A ^a   Leverve, X ^b   Pichard, C ^a  

^a UNIVERSITY HOSPITAL   (Switzerland)

^b UNIV GRENOBLE ALPES   (France)

Author keywords

Body weight; Enteritis; Growth hormone; Radiation; Rats

Indexed keywords

RECOMBINANT GROWTH HORMONE; GROWTH HORMONE;

ABDOMINAL DISEASE; ABDOMINAL RADIOTHERAPY; ARTICLE; BODY GROWTH; BODY WEIGHT; CONTROLLED STUDY; DRY WEIGHT; ILEUM; INTESTINE MUCOSA; JEJUNUM; MALE; NONHUMAN; PROTEIN CONTENT; RADIATION DOSE; RADIATION INJURY; RADIATION PROTECTION; RAT; STOMACH PROTECTION; WEIGHT REDUCTION; ANIMAL; DISEASE MODEL; DRUG EFFECT; ORGAN SIZE; PATHOLOGY; RADIATION EXPOSURE; RADIATION RESPONSE; SMALL INTESTINE; WISTAR RAT;

ANIMALS; BODY WEIGHT; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, RADIATION; GROWTH HORMONE; INTESTINAL MUCOSA; INTESTINE, SMALL; MALE; ORGAN SIZE; RADIATION INJURIES, EXPERIMENTAL; RATS; RATS, WISTAR;

EID: 0036899355     PISSN: 02615614     EISSN: None     Source Type: Journal    
DOI: 10.1054/clnu.2002.0579     Document Type: Article

References (23)

1. Dalla P. Intestinal malabsorption in patients undergoing abdominal radiation therapy. In: Sullivan ME (ed.). Gastrointestinal Radation injury, Richland: Washington, September 25-28, 1966: Excerpta Med Found 1968: 261-275
2. Chwals W J, Bistrian B R. Role of exogenous growth hormone and insulin-like growth factor I in malnutrition and acute metabolic stress: a hypothesis. Crit Care Med 1991; 19: 1317-1322
3. Ulshen M H, Dowling R H, Fuller C R, Zimmermann E M, Lund P K. Enhanced growth of small bowel in transgenic mice overexpressing growth hormone. Gastroenterol 1993; 104: 973
4. Peterson C A, Carey H V, Hinton P L, Lo H C, Ney D M. GH elevates serum IGF-I levels but does not alter mucosal atrophy in parenterally fed rats. Am J Physiol 1997; 272: G1100-G1108
5. Peterson C A, Gillingham M B, Mohapatra N K et al. Enterotrophic effect of insulin-like growth factor-I but not growth hormone and localized expression of insulin-like growth factor-I, insulin-like growth factor binding protein-3 and -5 mRNAs in jejunum of parenterally fed rats. J parenter Enteral Nutr 2000; 24: 288-295
6. Shulman D I, Hu C S, Duckett G, Lavallee-Grey M. Effects of short-term growth hormone therapy in rats undergoing 75% small intestinal resection. J Pediatr Gastroenterol Nutr 1992; 14: 3-11
7. Benhamou P H, Canarelli J P, Leroy C, De Boissieu D, Dupont C. Stimulation by recombinant human growth hormone of growth and development of remaining bowel after subtotal ileojejunectomy in rats. J Pediatr Gastroenterol Nutr 1994; 18: 446-452
8. Alexandrides T, Spiliotis J, Mylonas P et al. Effects of growth hormone and insulin-like growth factor-I on radiation enteritis. a comparative study. Eur Surg Res 1998; 30: 305-311
9. Gomez-de-Segura I A, Prieto I, Grande A G et al. Growth hormone reduces mortality and bacterial translocation in irradiated rats. Acta Oncol 1998; 37: 179-185
10. Subcommittee on Laboratory Animal Nutrition. Nutrient Requirements of Laboratory Animals. In: Nutrient Requirements of Domestic Animals. Washington, DC: National Academy of Sciences (Ed.), 1972: 314
11. Baumann G, Amburn K D, Buchanan T A. The effect of circulating growth hormone-binding protein on metabolic clearance, distribution, and degradation of human growth hormone. J Clin Endocrinol Metab 1987; 64: 657-660
12. Clark R G, Mortensen D L, Carlsson L M et al. Recombinant human growth hormone (GH)-binding protein enhances the growth-promoting activity of human GH in the rat. Endocrinology 1996; 137: 4308-4315
13. Bradford M M. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1973; 72: 248-254
14. Wobbes T, Verschueren R C, Lubbers E J, Jansen W, Paping R H. Surgical aspects of radiation enteritis of the small bowel. Dis Colon Rectum 1984; 27: 89-92
15. Boushey R P, Yusta B, Drucker D J. Glucagon-like peptide 2 decreases mortality and reduces the severity of indomethacin-induced murine enteritis. Am J Physiol 1999; 277: E937-E947
16. Mylonas P G, Matsouka P T, Papandoniou E V, Vagianos C, Kalfarentzos F, Alexandrides T K. Growth hormone and insulin-like growth factor I protect intestinal cells from radiation induced apoptosis. Mol Cell Endocrinol 2000; 160: 115-122
17. Vazquez I, Gomez-de-Segura I A, Grande A G et al. Protective effect of enriched diet plus growth hormone administration on radiation-induced intestinal injury and on its evolutionary pattern in the rat. Dig Dis Sci 1999; 44; 2350-2358
18. Heel K A, Kong S E, McCauley R D, Erber W N, Hall J C. The effect of minimum luminal nutrition on mucosal cellularity and immunity of the gut. J Gastroenterol Hepatol 1998; 13: 1015-1019
19. Souba W W, Klimberg V S, Copeland E M. Glutamine nutrition in the management of radiation enteritis. J Parent Enteral Nutr 1990; 14: 106S-108S
20. Carrillo A, Rising R, Cole C, Tverskaya R, Lifshitz F. Low dosages of exogenous growth hormone and its effect on growth in an animal model of suboptimal nutrition. Nutrition 2000; 16: 1074-1078
21. Hogenauer C, Santa Ana C A, Porter J L, Fordtran J S. Discrepancies between effects of recombinant growth hormone on absorption and secretion of water and electrolytes on the human jejunum compared to results reported on rat jejunum. Dig Dis Sci 2000; 45: 457-461
22. Tacke J, Bolder U, Herrmann A, Berger G, Jauch K W. Long-term risk of gastrointestinal tumor recurrence after post-operative treatment with recombinant human growth hormone. J Parent Enteral Nutr 2000; 24: 140-144
23. Slonim A E, Bulone L, Damore M B, Goldberg T, Wingertzahn M A, Mckinley M J. A preliminary study of growth hormone therapy for Crohn's disease. N Engl J Med 2000; 342: 1633-1637